VeriMom¿Es silybum marianum extract seguro durante el embarazo?
No harmonised CLP classification (no H360/H361 harmonised entry found), no EU Annex II/III restriction for Silybum marianum extract. Recent reviews and animal studies show either absence of reproductive/developmental toxicity or protective effects from silymarin; human data in pregnancy are scarce so regulators (NCCIH/EMA summaries) caution use but do not list a reproductive hazard. Topical cosmetic use would give low but measurable exposure. Sources: PubMed reviews and animal studies, NCCIH, ECHA registration summary. (PubMed review: Protective effects of silymarin on reproductive toxicity; animal developmental study: silymarin during pregnancy/lactation; NCCIH: limited data on pregnancy/breastfeeding; ECHA registration/listing shows registration dossier but no harmonised H361 classification).
Pregnancy-safe products containing silybum marianum extract
Alternativas seguras a silybum marianum extract en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es silybum marianum extract seguro durante el embarazo?
- No harmonised CLP classification (no H360/H361 harmonised entry found), no EU Annex II/III restriction for Silybum marianum extract. Recent reviews and animal studies show either absence of reproductive/developmental toxicity or protective effects from silymarin; human data in pregnancy are scarce so regulators (NCCIH/EMA summaries) caution use but do not list a reproductive hazard. Topical cosmetic use would give low but measurable exposure. Sources: PubMed reviews and animal studies, NCCIH, ECHA registration summary. (PubMed review: Protective effects of silymarin on reproductive toxicity; animal developmental study: silymarin during pregnancy/lactation; NCCIH: limited data on pregnancy/breastfeeding; ECHA registration/listing shows registration dossier but no harmonised H361 classification).
- ¿Es silybum marianum extract seguro durante la lactancia?
- Human data are limited. Some small/unpublished reports suggest low or non‑measurable excretion of silymarin into breastmilk, but evidence is insufficient and agencies advise caution. Topical cosmetic exposure would result in low systemic levels for the lactating parent, so infant exposure via milk from topical use is expected to be low but not zero. (Sources: NCCIH, EFSA/EFSA‑referenced report, PubMed studies).
- ¿Es silybum marianum extract seguro para la piel del bebé?
- No direct evidence of developmental or infant dermal toxicity. Because infants 0–3 years have a thinner/immature skin barrier and higher surface‑area‑to‑body‑weight, exposure score is increased by +1 compared with adults if the ingredient has measurable absorption. Silymarin components are moderately lipophilic and can be absorbed to a small degree; therefore infant dermal exposure is assessed as moderate. No infant‑specific hazards or CMR classifications were identified. (Sources: PubMed reviews, ECHA registration dossier, EWG ingredient page).
- ¿Cómo puntúa VeriMom a silybum marianum extract?
- VeriMom puntúa silybum marianum extract en 33/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a silybum marianum extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a silybum marianum extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.